← Back to Clinical Trials
Recruiting NCT06233682

NCT06233682 The Enriched Environment as an Integrated Tool in the Ward Setting

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06233682
Status Recruiting
Phase
Sponsor University of Padova
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2024-12-03
Primary Completion 2025-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Enriched environment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2024-12-03 with a primary completion date of 2025-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this longitudinal interventional study is to integrate the enriched environment (EE) in the context of the Neurology Clinic ward of the General Hospital - University of Padua, by verifying its effectiveness and impact on psychological well-being, functional recovery, activity level, and quality of life in people with stroke.

Eligibility Criteria

Inclusion Criteria: * Ischaemic or haemorrhagic stroke, in any territory, occurring at least 24 hours before enrollment; * Participant consent to participate in the study; * Mecial stabilisation. Exclusion Criteria: * Uncooperative participant, as assessed by theMontreal Cognitive Assessment scale \< 15 * medically not stabtability and/or reduced level of consciousness and/or psychomotor agitation; * Lack of trunk control (score \<12 in item 3 of the Trunk Control Test: balance in sitting position) such that it is impossible to maintain a sitting position or a safe posture in a wheelchair; * Speech evaluation confirming comprehension aphasia hampering understanding of informed consent.

Contact & Investigator

Central Contact

Francesca Venturini

✉ ce.sperimentazione@aopd.veneto.it

📞 049 8212341

Principal Investigator

Alessandra Del Felice, MD, PhD

PRINCIPAL INVESTIGATOR

University of Padova

Frequently Asked Questions

Who can join the NCT06233682 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06233682 currently recruiting?

Yes, NCT06233682 is actively recruiting participants. Contact the research team at ce.sperimentazione@aopd.veneto.it for enrollment information.

Where is the NCT06233682 trial being conducted?

This trial is being conducted at Padova, Italy.

Who is sponsoring the NCT06233682 clinical trial?

NCT06233682 is sponsored by University of Padova. The principal investigator is Alessandra Del Felice, MD, PhD at University of Padova. The trial plans to enroll 50 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology